Back to Search
Start Over
High prevalence of phenotypic pyrazinamide resistance and its association with pncA gene mutations in Mycobacterium tuberculosis isolates from Uganda.
- Source :
-
PloS one [PLoS One] 2020 May 15; Vol. 15 (5), pp. e0232543. Date of Electronic Publication: 2020 May 15 (Print Publication: 2020). - Publication Year :
- 2020
-
Abstract
- Introduction: Susceptibility testing for pyrazinamide (PZA), a cornerstone anti-TB drug is not commonly done in Uganda because it is expensive and characterized with technical difficulties thus resistance to this drug is less studied. Resistance is commonly associated with mutations in the pncA gene and its promoter region. However, these mutations vary geographically and those conferring phenotypic resistance are unknown in Uganda. This study determined the prevalence of PZA resistance and its association with pncA mutations.<br />Materials and Methods: Using a cross-sectional design, archived isolates collected during the Uganda national drug resistance survey between 2008-2011 were sub-cultured. PZA resistance was tested by BACTEC Mycobacterial Growth Indicator Tube (MGIT) 960 system. Sequence reads were downloaded from the NCBI Library and bioinformatics pipelines were used to screen for PZA resistance-conferring mutations.<br />Results: The prevalence of phenotypic PZA resistance was found to be 21%. The sensitivity and specificity of pncA sequencing were 24% (95% CI, 9.36-45.13%) and 100% (73.54% - 100.0%) respectively. We identified four mutations associated with PZA phenotypic resistance in Uganda; K96R, T142R, R154G and V180F.<br />Conclusion: There is a high prevalence of phenotypic PZA resistance among TB patients in Uganda. The low sensitivity of pncA gene sequencing confirms the already documented discordances suggesting other mechanisms of PZA resistance in Mycobacterium tuberculosis.<br />Competing Interests: The authors have declared that no competing interests exist.
- Subjects :
- Drug Resistance, Multiple, Bacterial genetics
Humans
Microbial Sensitivity Tests
Mutation
Mycobacterium tuberculosis genetics
Prevalence
Tuberculosis, Multidrug-Resistant microbiology
Tuberculosis, Pulmonary microbiology
Uganda epidemiology
Amidohydrolases genetics
Antitubercular Agents therapeutic use
Mycobacterium tuberculosis drug effects
Pyrazinamide therapeutic use
Tuberculosis, Multidrug-Resistant drug therapy
Tuberculosis, Pulmonary drug therapy
Subjects
Details
- Language :
- English
- ISSN :
- 1932-6203
- Volume :
- 15
- Issue :
- 5
- Database :
- MEDLINE
- Journal :
- PloS one
- Publication Type :
- Academic Journal
- Accession number :
- 32413052
- Full Text :
- https://doi.org/10.1371/journal.pone.0232543